Published in PLoS One on April 04, 2012
HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease. Stem Cell Reports (2017) 1.87
Alzheimer's disease and stem cell therapy. Exp Neurobiol (2014) 0.86
Regenerative medicine in Alzheimer's disease. Transl Res (2013) 0.85
The use of regenerative medicine in the management of invasive bladder cancer. Adv Urol (2012) 0.77
Stem Cell Therapy for the Central Nervous System in Lysosomal Storage Diseases. Hum Gene Ther (2016) 0.75
Targeting β-secretase with RNAi in neural stem cells for Alzheimer's disease therapy. Neural Regen Res (2013) 0.75
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 19.30
User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage (2006) 18.68
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med (2008) 17.09
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 6.12
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet (2003) 5.92
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A (2004) 4.70
A neurovascular niche for neurogenesis after stroke. J Neurosci (2006) 4.40
Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem (2004) 4.27
Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A (1995) 3.89
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med (2005) 3.46
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A (2009) 2.96
GFP-like proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol Biol Evol (2004) 2.82
Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron (2011) 2.67
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med (2005) 2.43
Microglia instruct subventricular zone neurogenesis. Glia (2006) 2.02
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem (2006) 1.98
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci (2011) 1.86
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci (2006) 1.65
Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med (2007) 1.55
Neural stem cells improve memory in an inducible mouse model of neuronal loss. J Neurosci (2007) 1.46
Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2010) 1.45
Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp Neurol (2006) 1.33
Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res (2002) 1.32
Diffusion heterogeneity and anisotropy in rat hippocampus. Neuroreport (1998) 1.20
A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A (2004) 1.18
Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J Neuroinflammation (2009) 1.08
Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain. Development (2006) 1.04
Evolution of anisotropic diffusion in the developing rat corpus callosum. J Neurophysiol (1997) 1.00
Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo. J Neurosci Methods (2010) 0.94
The relationship between SDF-1alpha/CXCR4 and neural stem cells appearing in damaged area after traumatic brain injury in rats. Neurol Res (2009) 0.92
Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. Neurosci Lett (1996) 0.91
Targeted expression of two proteins in neural retina using self-inactivating, insulated lentiviral vectors carrying two internal independent promoters. Mol Vis (2007) 0.91
Transplantation of stem cells from the adult human brain to the adult rat brain. Neurosurgery (2007) 0.90
Embryonic stem cell-derived neural precursor cells improve memory dysfunction in Abeta(1-40) injured rats. Neurosci Res (2008) 0.89
Neurogenic astrocytes transplanted into the adult mouse lateral ventricle contribute to olfactory neurogenesis, and reveal a novel intrinsic subependymal neuron. Neuroscience (2006) 0.87
The velum interpositum revisited and redefined. Surg Radiol Anat (2007) 0.85
Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success. PLoS Curr (2011) 0.79
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet (2003) 5.92
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia (2002) 5.81
BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci (2005) 3.23
Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet (2003) 2.64
Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia (2005) 2.62
Microglia: biology and pathology. Acta Neuropathol (2009) 2.51
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med (2005) 2.43
Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer. Cancer Res (2009) 2.40
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis (2005) 2.22
Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol (2003) 2.20
High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol Dis (2002) 2.09
Phenotypic and functional characterization of adult brain neuropoiesis. Proc Natl Acad Sci U S A (2005) 2.08
Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres. Proc Natl Acad Sci U S A (2002) 2.04
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci (2005) 2.03
Microglia instruct subventricular zone neurogenesis. Glia (2006) 2.02
Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis (2002) 1.96
Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet (2009) 1.79
Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem Cells (2005) 1.73
Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis (2005) 1.69
Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A (2009) 1.67
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet (2002) 1.67
Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci (2002) 1.66
A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem (2008) 1.65
GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol Cell (2004) 1.64
Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. Hum Mol Genet (2005) 1.63
Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol Genomics (2003) 1.62
Microglia in the aging brain. J Neuropathol Exp Neurol (2006) 1.60
Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation. J Neurochem (2006) 1.59
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis (2003) 1.59
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med (2013) 1.59
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (2013) 1.50
Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. Cancer Res (2009) 1.46
Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2010) 1.45
Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci (2008) 1.44
Light-driven cone arrestin translocation in cones of postnatal guanylate cyclase-1 knockout mouse retina treated with AAV-GC1. Invest Ophthalmol Vis Sci (2006) 1.39
Effects of tango on functional mobility in Parkinson's disease: a preliminary study. J Neurol Phys Ther (2007) 1.38
Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet (2004) 1.38
Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res (2007) 1.35
Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol (2010) 1.34
Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS. PLoS One (2008) 1.34
Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci (2007) 1.34
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum Mol Genet (2002) 1.33
N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease. Cell Cycle (2007) 1.31
Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J Neurosci (2003) 1.31
Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem (2007) 1.27
Comprehensive characterization and failure modes of tungsten microwire arrays in chronic neural implants. J Neural Eng (2012) 1.27
The effects of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol (2007) 1.26
An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet (2010) 1.26
Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models. J Neuropathol Exp Neurol (2007) 1.25
Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J Neuroinflammation (2007) 1.21
Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia (2008) 1.21
Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J Neurosci (2013) 1.20
Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1. J Biol Chem (2008) 1.20
Temporally restricted substrate interactions direct fate and specification of neural precursors derived from embryonic stem cells. Proc Natl Acad Sci U S A (2006) 1.20
Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One (2013) 1.19
PCR inhibition by reverse transcriptase leads to an overestimation of amplification efficiency. Nucleic Acids Res (2005) 1.18
Cone cell survival and downregulation of GCAP1 protein in the retinas of GC1 knockout mice. Invest Ophthalmol Vis Sci (2004) 1.17
Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J Biol Chem (2010) 1.16
Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology (2005) 1.15
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging (2004) 1.15
Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol Neurodegener (2011) 1.14
Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol (2010) 1.13
Microglial pathology. Acta Neuropathol Commun (2014) 1.13
Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model. Hum Mol Genet (2010) 1.12
Lentiviral expression of retinal guanylate cyclase-1 (RetGC1) restores vision in an avian model of childhood blindness. PLoS Med (2006) 1.11
Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum Mol Genet (2004) 1.11
Purification of immature neuronal cells from neural stem cell progeny. PLoS One (2011) 1.11
GC1 deletion prevents light-dependent arrestin translocation in mouse cone photoreceptor cells. Invest Ophthalmol Vis Sci (2005) 1.09
Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J Neurochem (2008) 1.09
Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain (2010) 1.07
Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene. J Neuroimmunol (2006) 1.07
Viral vector-mediated delivery of estrogen receptor-alpha to the hippocampus improves spatial learning in estrogen receptor-alpha knockout mice. Mol Ther (2008) 1.06
Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. Exp Biol Med (Maywood) (2009) 1.06
Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding. Protein Sci (2012) 1.06
Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia (2004) 1.05
Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability. J Biol Chem (2006) 1.05
A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy. Pediatr Res (2010) 1.04
Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain. Development (2006) 1.04
Telomeres shorten with age in rat cerebellum and cortex in vivo. J Anti Aging Med (2003) 1.04
Quantitative assessment of macromolecular concentration during direct infusion into an agarose hydrogel phantom using contrast-enhanced MRI. Magn Reson Imaging (2008) 1.04
Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res (2013) 1.03
Effect of heterogeneous vasculature on interstitial transport within a solid tumor. Microvasc Res (2006) 1.03
Neuron-to-astrocyte transition: phenotypic fluidity and the formation of hybrid asterons in differentiating neurospheres. J Comp Neurol (2005) 1.01
Common astrocytic programs during brain development, injury and cancer. Trends Neurosci (2009) 1.01
TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol (2002) 1.01
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiol Dis (2005) 1.01
Production of neurospheres from CNS tissue. Methods Mol Biol (2008) 1.01
Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol Aging (2007) 1.00
Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet (2011) 1.00
Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE. Neurobiol Dis (2003) 0.99
Thinking laterally about neurodegenerative proteinopathies. J Clin Invest (2013) 0.99
Quiescent adult neural stem cells are exceptionally sensitive to cosmic radiation. Exp Neurol (2007) 0.99
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice. Exp Neurol (2004) 0.99
The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene. J Neurosci Res (2005) 0.98